Coronavirus

Brazilian officials admit to Pfizer error but don’t think Bolsonaro will budge

Health Ministry officials say the government made a mistake by not striking a deal with Pfizer. The order now is to purchase "B-rated" vaccines, cutting off their nose to spite their face.
Bolsonaro (center) and Health Minister Pazuello launch national vaccinations plan in December 2020. Photo: Isac Nóbrega/PR

As we explained in today’s Daily Briefing, the Brazilian Health Ministry announced a deal to purchase 20 million doses of Covaxin, the coronavirus vaccine developed by Indian lab Bharat Biotech. The agreement came as part of a strategy to boost vaccination efforts, which have suffered from a serious shortage of inputs and jabs, forcing several cities to momentarily suspend immunization campaigns. The Covaxin deal — valued at BRL 1.6 billion (USD 288 million) — will see doses arrive in Brazil between March and May.

However, according to government sources consulted by The Brazilian Report, there is more to the deal...

Less expensive than a coffee

Enjoy any plan of your choice for US$1 for the first month